| 2026 |
Zhang T, Huang CJ, Chen HT, Huang YH, Pan MH, Lee MH, Viard M, Hildesheim A, Pfeiffer RM, Carrington M, Chen CJ, Zhu B, Lenz TL, Jiang D*, (Yang HI*, Liu Z, HLA-DQB1*03:01 and risk of Hepatitis B virus-related hepatocellular carcinoma., HEPATOLOGY, vol. 83 (2), 374-386, 2026 |
| 2026 |
Tseng TC, Hosaka T, Pan MH, Liu CJ, Suzuki F, Chen CJ, Su TH, Kumada H, Yang WT, Yang HC, Liu CH, Chen PJ, (Yang HI*, Kao JH*, Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patients., HEPATOLOGY, vol. 83 (1), 142-155, 2026 |
| 2025 |
Liao KS, Zhou Y, Chung C, Kung CC, (Ren CT, Wu CY, Lou YW, Chuang PK, Imre B, Hsieh YSY, Wong CH*, Chemical and Enzymatic Synthesis of DisialylGb5 and Other Sialosides for Glycan Array Assembly and Evaluation of Siglec-Mediated Immune Checkpoint Inhibition., Molecules (Basel, Switzerland), vol. 30(11), 2025 |
| 2025 |
Chan MH*, Zhuang RE, Wei DH*, (Hsiao M, Biomimetic red blood cell membrane-coated FePt metal-organic framework nanoparticles: a multifunctional theranostic system for enhanced MRI and targeted therapy., Nanoscale, vol. 17(40), 23343-23353, 2025 |
| 2025 |
Chuang PK, Chung C, Liao KS, (Wong CH)*, Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade., Proceedings of the National Academy of Sciences of the United States of America, vol. 122(38), e2517415122, 2025 |
| 2025 |
Lin KY, Jiang JK, Lai JI, Lin SY, Ku YC, Lin MH, Yang CY, Lo LC, (Hsu TL, Chang YC*, Siglec-14-LGALS3BP glycoimmune axis shapes tumor-associated macrophage polarization and confers poor outcome in colorectal cancer., NPJ precision oncology, vol. 9(1), 398, 2025 |
| 2025 |
Bagheri N, Margvelani G, Chiang TW, Nelson PT, (Chuang TJ, Stamm S*, Circular RNAs from the MAPT and TARDBP genes: Novel players in neurodegeneration?, Neurochemistry international, vol. 189, 106019, 2025 |
| 2025 |
Hong MX, Wang BW, Lo LH, Jayalath GED, Lin WT, Yang YL, Tseng SP, Chen YH, Tsai WC, (Cheng WC, Liaw CC*, Pseudopeptides of Marine Vibrio spp. from Taiwan and Their Combined Treatment Effects with Commercial Antibiotics., Planta medica, vol. 91(6-07), 371-381, 2025 |
| 2025 |
Wang CP*, Yu KJ, Chen TC, Tsai MS, Kang CJ, Chien CY, Engels EA, Hua CH, Hsu WL, Chang YL, Dawsey SM, Wentzensen N, Shi J, Mao F, Cheung LC, Katki HA, Boyd E, Wu CT, Gutkind JS, Molinolo A, Limbach AL, Lingen MW, Lou PJ, (Chen CJ, Hildesheim A, Chaturvedi AK, Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in Taiwan., Oral oncology, vol. 162, 107210, 2025 |
| 2025 |
Liu CH, Yang ST, Chao WT, Lin CH, Lee YC, Lai CR, (Hsieh SL, Wang LW, Wang PH*, Targeting the ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti-VEGF resistance in endometrial cancer., International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, vol. 171(3), 1343-1354, 2025 |
| 2025 |
Liao TL*, Chen DY, (Hsieh SL, Yang YY, Chen YM, Tang KT, Chang CH, Yang SS, Platelet-derived mitochondria regulate lipid metabolism in nonalcoholic steatohepatitis through extracellular vesicles., Hepatology (Baltimore, Md.), vol. 82(3), 722-738, 2025 |
| 2025 |
Peng HY, Chang CW, Wu PH, Li LJ, Lin YL, (Hsiao M, Chang JY, Chang PM, Lee HL*, Chang WM*, Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression., International journal of molecular sciences, vol. 26(3), 1077, 2025 |
| 2025 |
Chung SY, Yeh YC, Huang CJ, Chiang NJ, Hsu DS, Chan MH, Lu ML, Hsu TS, Hung YP, Yeh CN, (Hsiao M, Chang YC, Wang YC, Chen MH*, Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma., Journal for immunotherapy of cancer, vol. 13(1), e010173, 2025 |
| 2025 |
Shimabukuro J, Shen CH, Hsueh TK, Chen TW, Tseng YC, Gannedi V, Dumalaog JS, Chang CH*, (Cheng TR)*, Yu CS*, Hung SC*, Streamlined Synthesis and Immunomodulatory Effects of Ulvan Oligosaccharides from Marine Green Algae., Journal of the American Chemical Society, vol. 147(36), 32951-32962, 2025 |
| 2025 |
Huang YT, Hsu YC, (Yang HI, Lee MH, Lai TH, Chen CJ, Huang YT*, Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study., Journal of epidemiology, vol. 35(1), 21-29, 2025 |
| 2025 |
Cao Jie-Ling, Guo Jie-He, Leung Will, Liu Ya-Ting, Tsai I-Lin, Huang Shu-Ling, (Wang Yi-Sheng)*, Lai Yin-Hung*, Do phenolic contents relate to their in-vitro cytotoxicity against colorectal cancer cell lines from Calvatia lilacina (puffball mushroom)?, Food Bioscience, vol. 66, 106193, 2025 |
| 2025 |
Shen Z, Liu Z, Wang H, Landrock D, Noh JY, Zang QS, (Lee CH, Farnell YZ, Chen Z, Sun Y*, Fructose induces inflammatory activation in macrophages and microglia through the nutrient-sensing ghrelin receptor., FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol. 39(4), e70412, 2025 |
| 2025 |
Chang YC, Hsieh ML, Lee HL, Hee SW, Chang CF, Yen HY, Chen YA, Chen YR, Chou YW, Li FA, Ke YY, Chen SY, Hung MS, Hung AF, Huang JY, Chiu CH, Lin SY, Shih SF, Hsu CN, Hwang JJ, Yeh TK, Cheng TR, Liao KC, Laio D, Lin SW, Chen TY, (Hu CM, Vogel U, Saar D, Kragelund BB, Tsou LK*, Tseng YH*, Chuang LM*, Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity., EMBO molecular medicine, vol. 17(5), 938-966, 2025 |
| 2025 |
Lin JS, Tzeng ZH, Dumalaog JS, (Hung SC)*, A streamlined synthetic approach to the truncated linear trisaccharide fragment of QS-21., Frontiers in Chemistry, vol. 13, 1650302, 2025 |
| 2025 |
Jackson SS*, Francis J, Pfeiffer RM, Proietti C, Coghill AE, Yu KJ, Sarathkumara YD, Hsu WL, Argirion I, Wang CP, (Chen CJ, Rothman N, Lan Q, Hildesheim A, Doolan DL, Liu Z, Sex Differences in Anti-Epstein-Barr Virus Antibody Responses., The Journal of infectious diseases, vol. 232(4), e671-e675, 2025 |
| 2025 |
Blechter B*, Hsiung CA*, Wang X, Zhang H, Seow WJ, Shi J, Chatterjee N, Kim HN, Wong MP, Hong YC, Wong JYY, Dai J, Hosgood HD, Wang Z, Chang IS, Choi J, Wang J, Song M, Hu W, Zheng W, Kim JH, Zhou B, Albanes D, Shin MH, Chung LP, An SJ, Zheng H, Yatabe Y, Zhang XC, Kim YT, Shu XO, Kim YC, Vermeulen RCH, Bassig BA, Chang J, Man Ho JC, Ji BT, Kubo M, Daigo Y, Momozawa Y, Kamatani Y, Honda T, Kunitoh H, Watanabe SI, Miyagi Y, Nakayama H, Matsumoto S, Tsuboi M, Goto K, Yin Z, Takahashi A, Goto A, Minamiya Y, Shimizu K, Tanaka K, Wu T, Wei F, Su J, Kim YH, Oh IJ, Fun Lee VH, Su WC, Chen YM, Chang GC, Chen KY, Huang MS, Lin HC, Seow A, Park JY, Kweon SS, (Chen CJ, Gao YT, Wu C, Qian B, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Tsai YH, Jung YJ, Guo H, Hu Z, Chen TY, Burdett L, Yeager M, Hutchinson A, Berndt SI, Wu W, Wang J, Choi JE, Park KH, Sung SW, Liu L, Kang CH, Chen CH, Xu J, Guan P, Tan W, Wang CL, Loon Sihoe AD, Chen Y, Choi YY, Kim JS, Yoon HI, Cai Q, Park IK, Xu P, He Q, Chen CY, Wu J, Lim WY, Chen KC, Chan JKC, Li J, Chen H, Yu CJ, Jin L, Fraumeni JF Jr, Liu J, Landi MT, Yamaji T, Yang Y, Hicks B, Wyatt K, Li SA, Ma H, Song B, Wang Z, Cheng S, Li X, Ren Y, Iwasaki M, Zhu J, Jiang G, Fei K, Wu G, Chien LH, Tsai FY, Yu J, Stevens VL, Yang PC, Lin D, Chen K, Wu YL, Matsuo K, Rothman N, Shiraishi K, Shen H, Chanock SJ, Kohno T, Lan Q, Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report., Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 20(4), 521-530, 2025 |
| 2025 |
Chen CJ)*, Wu CC, Wei SL, Lin LJ, Lee WC, Chiang CJ, Chien RN, Lu SN, National strategy for elimination of liver diseases in Taiwan., Journal of the Formosan Medical Association = Taiwan yi zhi, vol. 124 Suppl 2, S74-S83, 2025 |
| 2025 |
Lu SN, Wang JH, (Chen CJ)*, Changing epidemiology of hepatitis C virus infection and liver disease mortality in Taiwan., Journal of the Formosan Medical Association = Taiwan yi zhi, vol. 124 Suppl 2, S96-S101, 2025 |
| 2025 |
Huang YT, Hsu YC, Yang HI, Lee MH, Lai TH, (Chen CJ, Huang YT*, Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study., Journal of epidemiology, vol. 35(1), 21-29, 2025 |
| 2025 |
Lee S, Ahn C, Abe SK, Rahman MS, Islam MR, Saito E, An S, Sawada N, Shu XO, Koh WP, Cai H, Hozawa A, Kanemura S, Nagata C, You SL, Kang D, Kanehara R, Gao YT, Yuan JM, Wen W, Sugawara Y, Wada K, (Chen CJ, Yoo KY, Ahsan H, Chia KS, Shin A, Kim J, Lee JE, Matsuo K, Rothman N, Qiao YL, Zheng W, Boffetta P, Inoue M, Park SK*, Association Between Cardiometabolic Multimorbidity and 15-year Mortality in the Asia Cohort Consortium., Journal of epidemiology, vol. 35(7), 321-329, 2025 |
| 2025 |
Liao PJ, (Chen CJ, Seak CJ, Ting MK, Hsu KH*, Antagonistic effect of arsenic exposure and chronic hepatitis viral infection on hepatocellular carcinoma., Journal of the National Cancer Institute, vol. 117(11), 2372-2381, 2025 |
| 2025 |
Peng HY, Huang YL, Wu PH, Li LJ, Peng BY, Wu CY, Lin YL, (Hsiao M, Chang JY, Mu-Hsin Chang P, Lee HL, Chang WM*, The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responses., Cancer cell international, vol. 25(1), 114, 2025 |
| 2025 |
Ding YF, Ho KH, Lee WJ, Chen LH, Hsieh FK, Tung MC, Lin SH, (Hsiao M, Yang SF, Yang YC*, Chien MH*, Cyclic increase in the histamine receptor H1-ADAM9-Snail/Slug axis as a potential therapeutic target for EMT-mediated progression of oral squamous cell carcinoma., Cell death & disease, vol. 16(1), 191, 2025 |
| 2025 |
Chen SH*, Wu SY, Chang YX, Lui EN, Chang CK, Lin SW, (Hsiao M, Yang JM, Liang PH*, Blocking XIAP:CASP7-p19 selectively induces apoptosis of CASP3/DR malignancies by a novel reversible small molecule., Cell death & disease, vol. 16(1), 459, 2025 |
| 2025 |
Yang YF, He ZJ, Kuo HH, Lin YY, Kim CH, Cai HY, Chen CL, (Hsiao M, Chen YC, Chang PM*, Chang YC*, Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stress., Cell death discovery, vol. 11(1), 451, 2025 |
